Compare BME & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BME | CION |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Finance/Investors Services |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 547.5M | 464.0M |
| IPO Year | 2005 | 2011 |
| Metric | BME | CION |
|---|---|---|
| Price | $39.32 | $6.72 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 35.8K | ★ 685.3K |
| Earning Date | 01-01-0001 | 03-12-2026 |
| Dividend Yield | N/A | ★ 17.88% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.18 | $6.50 |
| 52 Week High | $42.74 | $11.07 |
| Indicator | BME | CION |
|---|---|---|
| Relative Strength Index (RSI) | 22.41 | 18.75 |
| Support Level | $35.48 | N/A |
| Resistance Level | $42.55 | $10.17 |
| Average True Range (ATR) | 0.60 | 0.27 |
| MACD | -0.26 | -0.11 |
| Stochastic Oscillator | 1.45 | 12.45 |
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.